Analysis of Current Situation and Countermeasures of Drug Supply Chain of Centralized Procurement in China

Authors

  • Qianqian Kong

DOI:

https://doi.org/10.54097/rhrzdx16

Keywords:

Centralized drug purchasing; drug supply chain strategy.

Abstract

After the implementation of centralized drug bidding and procurement, drug prices showed a downward trend, but also exposed some problems, based on the centralized procurement process, aiming at the problems existing in the operation of the supply chain of centralized drug procurement in the current market, put forward corresponding suggestions for the shortcomings of the operation mode of the supply chain of centralized drug procurement, and effectively under the bidding and procurement system, Make pharmaceutical enterprises responsible for patients, the environment and the government, and provide reference for the construction of China's drug supply chain management system.

Downloads

Download data is not yet available.

References

Chang, F. (2021). Analysis of the Core Elements of Drug Volume-based Procurement. Chinese Health Resources, 24(1), 15-19.

Sun, Y., Zhu, Z., & Yang, L. (2022). Factors influencing the price reduction of centrally organized drug volume-based procurement: An analysis. Chinese Health Policy Research, 15(02), 54-59.

Wang Q, Chen J. Progress and Prospect of Generic Drug Consistency Evaluation [J]. Chinese Journal of Modern Applied Pharmacy, 2019, 36 (4): 499-502. DOI:10.13748/j.cnki.issn1007-7693.2019.04.024.

Hu X, Ye X, Feng F, et al. Policy Implications and Reform Challenges of Centralized Procurement with Volume-Based Approach for Pharmaceuticals: Summary of the "Workshop on Policies for Centralized Procurement with Volume-Based Approach for Pharmaceuticals" [J]. Health Economics Research, 2020, 37(12):26-27,31.

Fu, S., & Sun, S. (2020). Design of incentive mechanisms for doctors in the era of "4+7 volume-based procurement". Chinese Hospital Management, 40(11), 38-39, 51.

Downloads

Published

06-03-2024

Issue

Section

Articles

How to Cite

Kong, Q. (2024). Analysis of Current Situation and Countermeasures of Drug Supply Chain of Centralized Procurement in China. Frontiers in Business, Economics and Management, 13(3), 363-365. https://doi.org/10.54097/rhrzdx16